Northwell Health (Data collection only)

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Diffuse large B-cell lymphoma

Running trials

• Active, not recruiting

  Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)

  NCT02570542· Phase 2· Memorial Sloan Kettering Cancer Center· Source